Patient characteristics
| Characteristic . | Cohort 1 (n = 45) . | Cohort 2 (n = 20) . | Total (n = 65) . | |||
|---|---|---|---|---|---|---|
| No. . | % . | No. . | % . | No. . | % . | |
| Female sex | 20 | 44 | 14 | 70 | 34 | 52 |
| Median age, y (range) | 31 (13-65) | 35 (19-59) | 33 (13-65) | |||
| Stage at initial diagnosis | ||||||
| Early | 22 | 49 | 13 | 65 | 35 | 54 |
| Advanced | 23 | 51 | 7 | 35 | 30 | 46 |
| Stage at relapse | ||||||
| Early | 23 | 51 | 13 | 65 | 36 | 55 |
| Advanced | 22 | 49 | 7 | 35 | 29 | 45 |
| Refractory | 25 | 56 | 9 | 45 | 34 | 52 |
| B symptoms | 9 | 20 | 1 | 5 | 10 | 15 |
| Extranodal disease | 19 | 42 | 5 | 25 | 24 | 37 |
| Bulk (>5 cm) | 12 | 27 | 4 | 20 | 16 | 25 |
| Characteristic . | Cohort 1 (n = 45) . | Cohort 2 (n = 20) . | Total (n = 65) . | |||
|---|---|---|---|---|---|---|
| No. . | % . | No. . | % . | No. . | % . | |
| Female sex | 20 | 44 | 14 | 70 | 34 | 52 |
| Median age, y (range) | 31 (13-65) | 35 (19-59) | 33 (13-65) | |||
| Stage at initial diagnosis | ||||||
| Early | 22 | 49 | 13 | 65 | 35 | 54 |
| Advanced | 23 | 51 | 7 | 35 | 30 | 46 |
| Stage at relapse | ||||||
| Early | 23 | 51 | 13 | 65 | 36 | 55 |
| Advanced | 22 | 49 | 7 | 35 | 29 | 45 |
| Refractory | 25 | 56 | 9 | 45 | 34 | 52 |
| B symptoms | 9 | 20 | 1 | 5 | 10 | 15 |
| Extranodal disease | 19 | 42 | 5 | 25 | 24 | 37 |
| Bulk (>5 cm) | 12 | 27 | 4 | 20 | 16 | 25 |